These accounts, for the year ended 31 March 2025, have been prepared by West Midlands Ambulance Service University NHS Foundation Trust in accordance with paragraphs 24 & 25 of Schedule 7 within the National Health Service Act 2006.
Anthony Marsh
Job title: Chief Executive Office
Date: 23 June 2025
Statement of Comprehensive Income
Note | 2024 to 2025 £000 | 2023 to 2024 £000 | |
---|---|---|---|
Operating income from patient care activities | 3 | 442,836 | 401,276 |
Other operating income | 4 | 13,763 | 13,032 |
Operating expenses | 7,9 | (455,974) | (412,502) |
Operating surplus from continuing operations | 625 | 1,806 | |
Finance income | 11 | 1,727 | 2,266 |
Finance expenses | 12 | (545) | (452) |
PDC dividends payable | (2,003) | (1,505) | |
Net finance costs | (821) | 309 | |
Other gains / (losses) | 13 | 227 | (47) |
Share of profit / (losses) of associates / joint arrangements | 21 | – | – |
(Losses) arising from transfers by absorption | 45 | (21) | – |
Corporation tax expense | – | – | |
Surplus for the year from continuing operations | 10 | 2,068 | |
Surplus / (deficit) on discontinued operations and the gain / (loss) on disposal of discontinued operations | 15 | – | – |
Surplus for the year | 10 | 2,068 |
Other comprehensive income
Will not be reStatement of Financial Positionclassified to income and expenditure:
Impairments | 8 | (1,509) | – |
Revaluations | 18 | 3,003 | 261 |
Share of comprehensive income from associates and joint ventures | 21 | – | – |
Fair value gains / (losses) on equity instruments designated at fair value through OCI | 22 | – | – |
Other recognised gains and losses | – | – | |
Remeasurements of the net defined benefit pension scheme liability / asset | 38 | – | – |
Other reserve movements | – | – | |
May be reclassified to income and expenditure when certain conditions are met: | |||
Fair value gains/(losses) on financial assets mandated at fair value through OCI | 22 | – | – |
Recycling gains/(losses) on disposal of financial assets mandated at fair value through OCI | 13 | – | – |
Foreign exchange gains / (losses) recognised directly in OCI | – | – | |
Total comprehensive income for the period | 1,504 | 2,329 |
Statement of Financial Position
Note | 31 March 2025 £000 | 31 March 2024 £000 | ||
---|---|---|---|---|
Non-current assets | ||||
Intangible assets | 15 | 1,015 | 1,157 | |
Property, plant and equipment | 16 | 67,233 | 76,598 | |
Right of use assets | 19 | 48,494 | 44,586 | |
Investment property | 20 | – | – | |
Investments in associates and joint ventures | 21 | – | – | |
Other investments / financial assets | 22 | – | – | |
Receivables | 25 | 676 | 704 | |
Other assets | 27 | – | – | |
Total non-current assets | 117,418 | 123,045 | ||
Current assets | ||||
Inventories | 24 | 2,974 | 3,545 | |
Receivables | 25 | 17,415 | 13,805 | |
Other investments / financial assets | 22 | – | – | |
Other assets | 27 | – | – | |
Non-current assets for sale and assets in disposal groups | 28.1 | 2,490 | – | |
Cash and cash equivalents | 29 | 35,543 | 36,463 | |
Total current assets | 58,422 | 53,813 | ||
Current liabilities | ||||
Trade and other payables | 30 | (30,863) | (34,685) | |
Borrowings | 32 | (7,213) | (4,386) | |
Other financial liabilities | 33 | – | – | |
Provisions | 34 | (3,405) | (5,910) | |
Other liabilities | 31 | (531) | (319) | |
Liabilities in disposal groups | 28.2 | – | – | |
Total current liabilities | (42,012) | (45,300) | ||
Total assets less current liabilities | 133,828 | 131,558 | ||
Non-current liabilities | ||||
Trade and other payables | 30 | – | – | |
Borrowings | 32 | (37,343) | (35,430) | |
Other financial liabilities | 33 | – | – | |
Provisions | 34 | (3,528) | (4,675) | |
Other liabilities | 31 | – | – | |
Total non-current liabilities | (40,871) | (40,105) | ||
Total assets employed | 92,957 | 91,453 | ||
Financed by | ||||
Public dividend capital | 44,473 | 44,473 | ||
Revaluation reserve | 11,244 | 9,756 | ||
Financial assets reserve | – | – | ||
Other reserves | 5,395 | 5,395 | ||
Merger reserve | – | – | ||
Income and expenditure reserve | 31,845 | 31,829 | ||
Total taxpayers’ equity | 92,957 | 91,453 |
The notes on pages B6 to B43 form part of these accounts.
Name:
Position: Chief Executive Officer
Date: 23 June 2025
Statement of Changes in Taxpayers Equity for the year ended 31 March 2025
Public dividend capital | Revaluation reserve | Financial assets reserve | Other reserves | Merger reserve | Income and expenditure reserve | Total | |
---|---|---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | £000 | £000 | |
Taxpayers’ and others’ equity at 1 April 2024 – brought forward | 44,473 | 9,756 | – | 5,395 | – | 31,829 | 91,453 |
At start of period for new FTs | – | – | – | – | – | – | – |
Surplus for the year | – | – | – | – | – | 10 | 10 |
Transfers by absorption: transfers between reserves | – | – | – | – | – | – | – |
Transfer from revaluation reserve to income and expenditure reserve for impairments arising from consumption of economic benefits | – | – | – | – | – | – | – |
Other transfers between reserves | – | – | – | – | – | – | – |
Impairments | – | (1,509) | – | – | – | – | (1,509) |
Revaluations | – | 3,003 | – | – | – | – | 3,003 |
Transfer to retained earnings on disposal of assets | – | (6) | – | – | – | 6 | – |
Share of comprehensive income from associates and joint ventures | – | – | – | – | – | – | – |
Fair value gains/(losses) on financial assets mandated at fair value through OCI | – | – | – | – | – | – | – |
Fair value gains/(losses) on equity instruments designated at fair value through OCI | – | – | – | – | – | – | – |
Recycling gains/(losses) on disposal of financial assets mandated at fair value through OCI | – | – | – | – | – | – | – |
Foreign exchange gains/(losses) recognised directly through OCI | – | – | – | – | – | – | – |
Other recognised gains and losses | – | – | – | – | – | – | – |
Remeasurements of the defined net benefit pension scheme liability/asset | – | – | – | – | – | – | – |
Public dividend capital received | – | – | – | – | – | – | – |
Public dividend capital repaid | – | – | – | – | – | – | – |
Public dividend capital written off | – | – | – | – | – | – | – |
Other movements in public dividend capital in year | – | – | – | – | – | – | – |
Other reserve movements | – | – | – | – | – | – | – |
Taxpayers’ and others’ equity at 31 March 2025 | 44,473 | 11,244 | – | 5,395 | – | 31,845 | 92,957 |
Statement of Changes in Taxpayers Equity for the year ended 31 March 2024
Public dividend capital | Revaluation reserve | Financial assets reserve | Other reserves | Merger reserve | Income and expenditure reserve | Total | |
---|---|---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | £000 | £000 | |
Taxpayers’ and others’ equity at 1 April 2023 – brought forward | 43,856 | 9,908 | – | 5,395 | – | 29,348 | 88,507 |
Prior period adjustment | – | – | – | – | – | – | – |
Taxpayers’ and others’ equity at 1 April 2023 – restated | 43,856 | 9,908 | – | 5,395 | – | 29,348 | 88,507 |
Application of IFRS 16 measurement principles to PFI liability on 1 April 2023 | – | – | – | – | – | – | – |
At start of period for new FTs | – | – | – | – | – | – | – |
Surplus for the year | – | – | – | – | – | 2,068 | 2,068 |
Transfers by absorption: transfers between reserves | – | – | – | – | – | – | – |
Transfer from revaluation reserve to income and expenditure reserve for impairments arising from consumption of economic benefits | – | – | – | – | – | – | – |
Other transfers between reserves | – | – | – | – | – | – | – |
Impairments | – | – | – | – | – | – | – |
Revaluations | – | 261 | – | – | – | – | 261 |
Transfer to retained earnings on disposal of assets | – | (413) | – | – | – | 413 | – |
Share of comprehensive income from associates and joint ventures | – | – | – | – | – | – | – |
Fair value gains/(losses) on financial assets mandated at fair value through OCI | – | – | – | – | – | – | – |
Fair value gains/(losses) on equity instruments designated at fair value through OCI | – | – | – | – | – | – | – |
Recycling gains/(losses) on disposal of financial assets mandated at fair value through OCI | – | – | – | – | – | – | – |
Foreign exchange gains/(losses) recognised directly through OCI | – | – | – | – | – | – | – |
Other recognised gains and losses | – | – | – | – | – | – | – |
Remeasurements of the defined net benefit pension scheme liability/asset | – | – | – | – | – | – | – |
Public dividend capital received | 617 | – | – | – | – | – | 617 |
Public dividend capital repaid | – | – | – | – | – | – | – |
Public dividend capital written off | – | – | – | – | – | – | – |
Other movements in public dividend capital in year | – | – | – | – | – | – | – |
Other reserve movements | – | – | – | – | – | – | – |
Taxpayers’ and others’ equity at 31 March 2024 | 44,473 | 9,756 | – | 5,395 | – | 31,829 | 91,453 |
Information on reserves
Public dividend capital
Public dividend capital (PDC) is a type of public sector equity finance based on the excess of assets over liabilities at the time of establishment of the predecessor NHS organisation. Additional PDC may also be issued to trusts by the Department of Health and Social Care. A charge, reflecting the cost of capital utilised by the trust, is payable to the Department of Health as the public dividend capital dividend.
Revaluation reserve
Increases in asset values arising from revaluations are recognised in the revaluation reserve, except where, and to the extent that, they reverse impairments previously recognised in operating expenses, in which case they are recognised in operating income. Subsequent downward movements in asset valuations are charged to the revaluation reserve to the extent that a previous gain was recognised unless the downward movement represents a clear consumption of economic benefit or a reduction in service potential.
Other reserves
Other reserves were created from PDC on the dissolution of the following Ambulance Services:
Hereford & Worcester Ambulance Service NHS Trust (30.06.06)
Coventry & Warwickshire Ambulance NHS Trust (30.06.06)
Staffordshire Ambulance Service NHS Trust (30.09.07)
The 3 ambulance Trusts merged with the West Midlands Ambulance Service NHS Trust
Income and expenditure reserve
The balance of this reserve is the accumulated surpluses and deficits of the trust.
Statement of Cash Flows
2024 to 2025 | 2023 to 2024 | ||
---|---|---|---|
Note | £000 | £000 | |
Cash flows from operating activities | |||
Operating surplus | 625 | 1,806 | |
Non-cash income and expense: | |||
Depreciation and amortisation | 7.1 | 25,343 | 24,553 |
Net impairments | 8 | 3,583 | (21) |
Income recognised in respect of capital donations | 4 | (1,029) | (314) |
Amortisation of PFI deferred credit | – | – | |
Non-cash movements in on-SoFP pension liability | – | – | |
(Increase) / decrease in receivables and other assets | (3,651) | 15,210 | |
Decrease / (Increase) in inventories | 571 | (376) | |
(Decrease) in payables and other liabilities | (4,988) | (20,879) | |
(Decrease) / increase in provisions | (3,696) | 2,764 | |
Tax (paid) / received | – | – | |
Operating cash flows from discontinued operations | – | – | |
Other movements in operating cash flows | – | – | |
Net cash flows from operating activities | 16,758 | 22,743 | |
Cash flows from investing activities | |||
Interest received | 1,727 | 2,266 | |
Purchase and sale of financial assets / investments | – | – | |
Purchase of intangible assets | (285) | (447) | |
Sales of intangible assets | – | – | |
Purchase of PPE and investment property | (11,686) | (15,304) | |
Sales of PPE and investment property | 645 | 950 | |
Initial direct costs or up front payments in respect of new right of use assets (lessee) | – | – | |
Receipt of cash lease incentives (lessee) | – | – | |
Lease termination fees paid (lessee) | – | (12) | |
Receipt of cash donations to purchase assets | 1,029 | – | |
Prepayment of PFI capital contributions | – | – | |
Finance lease receipts (principal and interest) | – | – | |
Investing cash flows from discontinued operations | – | – | |
Cash from acquisitions / disposals of subsidiaries | – | – | |
Net cash flows (used in) investing activities | (8,570) | (12,547) | |
Cash flows from financing activities | |||
Public dividend capital received | – | 617 | |
Public dividend capital repaid | – | – | |
Movement on loans from DHSC | – | – | |
Movement on other loans | – | – | |
Other capital receipts | – | – | |
Capital element of lease rental payments | (6,908) | (5,605) | |
Capital element of PFI, LIFT and other service concession payments | – | – | |
Interest on loans | – | – | |
Other interest | – | – | |
Interest paid on lease liability repayments | (501) | (372) | |
Interest paid on PFI, LIFT and other service concession obligations | – | – | |
PDC dividend (paid) | (1,699) | (1,596) | |
Financing cash flows of discontinued operations | – | – | |
Cash flows from (used in) other financing activities | – | – | |
Net cash flows (used in) financing activities | (9,108) | (6,956) | |
(Decrease) / increase in cash and cash equivalents | (920) | 3,240 | |
Cash and cash equivalents at 1 April – brought forward | 36,463 | 33,223 | |
Prior period adjustments | – | ||
Cash and cash equivalents at 1 April – restated | 36,463 | 33,223 | |
Cash and cash equivalents at start of period for new FTs | – | – | |
Cash and cash equivalents transferred under absorption accounting | 45 | – | – |
Unrealised gains / (losses) on foreign exchange | – | – | |
Cash and cash equivalents at 31 March | 29.1 | 35,543 | 36,463 |
Note 1 Accounting policies and other information
Note 1.1 Basis of preparation
NHS England has directed that the financial statements of the Trust shall meet the accounting requirements of the Department of Health and Social Care Group Accounting Manual (GAM), which shall be agreed with HM Treasury. Consequently, the following financial statements have been prepared in accordance with the GAM 2024 to 2025 issued by the Department of Health and Social Care. The accounting policies contained in the GAM follow International Financial Reporting Standards to the extent that they are meaningful and appropriate to the NHS, as determined by HM Treasury, which is advised by the Financial Reporting Advisory Board. Where the GAM permits a choice of accounting policy, the accounting policy that is judged to be most appropriate to the particular circumstances of the Trust for the purpose of giving a true and fair view has been selected. The particular policies adopted are described below. These have been applied consistently in dealing with items considered material in relation to the accounts.
Note 1.1.1 Accounting convention
These accounts have been prepared under the historical cost convention modified to account for the revaluation of property, plant and equipment, intangible assets, inventories and certain financial assets and financial liabilities.
Note 1.1.2 Going concern
These financial statements have been prepared on a going concern basis. The financial reporting framework applicable to NHS bodies, derived from the HM Treasury Financial Reporting Manual, defines that the anticipated continued provision of the entity’s services in the public sector is normally sufficient evidence of going concern. The directors have a reasonable expectation that this will continue to be the case.
Note 1.2.1 Revenue from contracts with customers
Where income is derived from contracts with customers, it is accounted for under IFRS 15. The GAM expands the definition of a contract to include legislation and regulations which enables an entity to receive cash or another financial asset that is not classified as a tax by the Office of National Statistics (ONS).
Revenue in respect of goods/services provided is recognised when (or as) performance obligations are satisfied by transferring promised goods/services to the customer and is measured at the amount of the transaction price allocated to those performance obligations. At the year end, the Trust accrues income relating to performance obligations satisfied in that year. Where the Trust’s entitlement to consideration for those goods or services is unconditional a contract receivable will be recognised. Where entitlement to consideration is conditional on a further factor other than the passage of time, a contract asset will be recognised. Where consideration received or receivable relates to a performance obligation that is to be satisfied in a future period, the income is deferred and recognised as a contract liability.
Revenue from NHS contracts
The main source of income for the Trust is contracts with commissioners for health care services. Funding envelopes are set at an Integrated Care System (ICS) level. The majority of the Trust’s NHS income is earned from NHS commissioners under the NHS Payment Scheme (NHSPS). The NHSPS sets out rules to establish the amount payable to trusts for NHS-funded secondary healthcare.
The Trust also receives income from commissioners under Commissioning for Quality Innovation (CQUIN) and Best Practice Tariff (BPT) schemes. Delivery under these schemes is part of how care is provided to patients. As such CQUIN and BPT payments are not considered distinct performance obligations in their own right; instead they form part of the transaction price for performance obligations under the overall contract with the commissioner and are accounted for as variable consideration under IFRS 15. Payment for CQUIN and BTP on non-elective services is included in the fixed element of API contracts with adjustments for actual achievement being made at the end of the year. BPT earned on elective activity is included in the variable element of API contracts and paid in line with actual activity performed.
Elective recovery funding provides additional funding to integrated care boards to fund the commissioning of elective services within their systems. Trusts do not directly earn elective recovery funding, instead earning income for actual activity performed under API contract arrangements as explained above. The level of activity delivered by the trust contributes to system performance and therefore the availability of funding to the trust’s commissioners.
Note 1.6 Property, plant and equipment
Recognition
Property, plant and equipment is capitalised where:
- it is held for use in delivering services or for administrative purposes;
- it is probable that future economic benefits will flow to, or service potential be provided to, the trust;
- it is expected to be used for more than one financial year;
- the cost of the item can be measured reliably; and
- the item has a cost of at least £5,000; or
- collectively, a number of items have a cost of at least £5,000 and individually have a cost of more than £250, where the assets are functionally interdependent, they had broadly simultaneous purchase dates, are anticipated to have similar disposal dates and are under single managerial control; or
- items form part of the initial equipping and setting-up cost of a new building or unit, irrespective of their individual or collective cost.
Where a large asset, for example a building, includes a number of components with significantly different asset lives, eg, plant and equipment, then these components are treated as separate assets and depreciated over their own useful economic lives.
Subsequent expenditure
Subsequent expenditure relating to an item of property, plant and equipment is recognised as an increase in the carrying amount of the asset when it is probable that additional future economic benefits or service potential deriving from the cost incurred to replace a component of such item will flow to the enterprise and the cost of the item can be determined reliably. Where a component of an asset is replaced, the cost of the replacement is capitalised if it meets the criteria for recognition above. The carrying amount of the part replaced is de-recognised. Other expenditure that does not generate additional future economic benefits or service potential, such as repairs and maintenance, is charged to the Statement of Comprehensive Income in the period in which it is incurred.
Measurement
Valuation
All property, plant and equipment assets are measured initially at cost, representing the costs directly attributable to acquiring or constructing the asset and bringing it to the location and condition necessary for it to be capable of operating in the manner intended by management.
Assets are measured subsequently at valuation. Assets which are held for their service potential and are in use (ie operational assets used to deliver either front line services or back office functions) are measured at their current value in existing use. Assets that were most recently held for their service potential but are surplus with no plan to bring them back into use are measured at fair value where there are no restrictions on sale at the reporting date and where they do not meet the definitions of investment properties or assets held for sale.
Revaluations of property, plant and equipment are performed with sufficient regularity to ensure that carrying amounts are not materially different from those that would be determined at the end of the reporting period. Current values in existing use are determined as follows:
- Land and non-specialised buildings – market value for existing use
- Specialised buildings – depreciated replacement cost on a modern equivalent asset basis
For specialised assets, current value in existing use is interpreted as the present value of the asset’s remaining service potential, which is assumed to be at least equal to the cost of replacing that service potential. Specialised assets are therefore valued at their depreciated replacement cost (DRC) on a modern equivalent asset (MEA) basis. An MEA basis assumes that the asset will be replaced with a modern asset of equivalent capacity and location requirements of the services being provided. Assets held at depreciated replacement cost have been valued on an alternative site basis where this would meet the location requirements.
Valuation guidance issued by the Royal Institute of Chartered Surveyors states that valuations are performed net of VAT where the VAT is recoverable by the entity.
Properties in the course of construction for service or administration purposes are carried at cost, less any impairment loss. Cost includes professional fees. Assets are revalued and depreciation commences when they are brought into use.
IT equipment, transport equipment, furniture and fittings, and plant and machinery that are held for operational use are valued at depreciated historic cost where these assets have short useful lives or low values or both, as this is not considered to be materially different from current value in existing use.
Information on reserves
Public dividend capital
Public dividend capital (PDC) is a type of public sector equity finance based on the excess of assets over liabilities at the time of establishment of the predecessor NHS organisation. Additional PDC may also be issued to trusts by the Department of Health and Social Care. A charge, reflecting the cost of capital utilised by the trust, is payable to the Department of Health as the public dividend capital dividend.
Revaluation reserve
Increases in asset values arising from revaluations are recognised in the revaluation reserve, except where, and to the extent that, they reverse impairments previously recognised in operating expenses, in which case they are recognised in operating income. Subsequent downward movements in asset valuations are charged to the revaluation reserve to the extent that a previous gain was recognised unless the downward movement represents a clear consumption of economic benefit or a reduction in service potential.
Other reserves
Other reserves were created from PDC on the dissolution of the following Ambulance Services: Hereford & Worcester Ambulance Service NHS Trust (30.06.06) Coventry & Warwickshire Ambulance NHS Trust (30.06.06)
Staffordshire Ambulance Service NHS Trust (30.09.07) The 3 ambulance Trusts merged with the West Midlands Ambulance Service NHS Trust
Income and expenditure reserve
The balance of this reserve is the accumulated surpluses and deficits of the trust.
Statement of Cash Flows
2024 to 2025 | 2023 to 2024 | ||
---|---|---|---|
Note | £000 | £000 | |
Cash flows from operating activities | |||
Operating surplus | 625 | 1,806 | |
Non-cash income and expense: | |||
Depreciation and amortisation | 7.1 | 25,343 | 24,553 |
Net impairments | 8 | 3,583 | (21) |
Income recognised in respect of capital donations | 4 | (1,029) | (314) |
Amortisation of PFI deferred credit | – | – | |
Non-cash movements in on-SoFP pension liability | – | – | |
(Increase) / decrease in receivables and other assets | (3,651) | 15,210 | |
Decrease / (Increase) in inventories | 571 | (376) | |
(Decrease) in payables and other liabilities | (4,988) | (20,879) | |
(Decrease) / increase in provisions | (3,696) | 2,764 | |
Tax (paid) / received | – | – | |
Operating cash flows from discontinued operations | – | – | |
Other movements in operating cash flows | – | – | |
Net cash flows from operating activities | 16,758 | 22,743 | |
Cash flows from investing activities | |||
Interest received | 1,727 | 2,266 | |
Purchase and sale of financial assets / investments | – | – | |
Purchase of intangible assets | (285) | (447) | |
Sales of intangible assets | – | – | |
Purchase of PPE and investment property | (11,686) | (15,304) | |
Sales of PPE and investment property | 645 | 950 | |
Initial direct costs or up front payments in respect of new right of use assets (lessee) | – | – | |
Receipt of cash lease incentives (lessee) | – | – | |
Lease termination fees paid (lessee) | – | (12) | |
Receipt of cash donations to purchase assets | 1,029 | – | |
Prepayment of PFI capital contributions | – | – | |
Finance lease receipts (principal and interest) | – | – | |
Investing cash flows from discontinued operations | – | – | |
Cash from acquisitions / disposals of subsidiaries | – | – | |
Net cash flows (used in) investing activities | (8,570) | (12,547) | |
Cash flows from financing activities | |||
Public dividend capital received | – | 617 | |
Public dividend capital repaid | – | – | |
Movement on loans from DHSC | – | – | |
Movement on other loans | – | – | |
Other capital receipts | – | – | |
Capital element of lease rental payments | (6,908) | (5,605) | |
Capital element of PFI, LIFT and other service concession payments | – | – | |
Interest on loans | – | – | |
Other interest | – | – | |
Interest paid on lease liability repayments | (501) | (372) | |
Interest paid on PFI, LIFT and other service concession obligations | – | – | |
PDC dividend (paid) | (1,699) | (1,596) | |
Financing cash flows of discontinued operations | – | – | |
Cash flows from (used in) other financing activities | – | – | |
Net cash flows (used in) financing activities | (9,108) | (6,956) | |
(Decrease) / increase in cash and cash equivalents | (920) | 3,240 | |
Cash and cash equivalents at 1 April – brought forward | 36,463 | 33,223 | |
Prior period adjustments | – | ||
Cash and cash equivalents at 1 April – restated | 36,463 | 33,223 | |
Cash and cash equivalents at start of period for new FTs | – | – | |
Cash and cash equivalents transferred under absorption accounting | 45 | – | – |
Unrealised gains / (losses) on foreign exchange | – | – | |
Cash and cash equivalents at 31 March | 29.1 | 35,543 | 36,463 |
Notes to the Accounts
Note 1 Accounting policies and other information
Note 1.1 Basis of preparation
NHS England has directed that the financial statements of the Trust shall meet the accounting requirements of the Department of Health and Social Care Group Accounting Manual (GAM), which shall be agreed with HM Treasury. Consequently, the following financial statements have been prepared in accordance with the GAM 2024 to 2025 issued by the Department of Health and Social Care. The accounting policies contained in the GAM follow International Financial Reporting Standards to the extent that they are meaningful and appropriate to the NHS, as determined by HM Treasury, which is advised by the Financial Reporting Advisory Board. Where the GAM permits a choice of accounting policy, the accounting policy that is judged to be most appropriate to the particular circumstances of the Trust for the purpose of giving a true and fair view has been selected. The particular policies adopted are described below. These have been applied consistently in dealing with items considered material in relation to the accounts.
Note 1.1.1 Accounting convention
These accounts have been prepared under the historical cost convention modified to account for the revaluation of property, plant and equipment, intangible assets, inventories and certain financial assets and financial liabilities.
Note 1.1.2 Going concern
These financial statements have been prepared on a going concern basis. The financial reporting framework applicable to NHS bodies, derived from the HM Treasury Financial Reporting Manual, defines that the anticipated continued provision of the entity’s services in the public sector is normally sufficient evidence of going concern. The directors have a reasonable expectation that this will continue to be the case.
Note 1.2.1 Revenue from contracts with customers
Where income is derived from contracts with customers, it is accounted for under IFRS 15. The GAM expands the definition of a contract to include legislation and regulations which enables an entity to receive cash or another financial asset that is not classified as a tax by the Office of National Statistics (ONS).
Revenue in respect of goods/services provided is recognised when (or as) performance obligations are satisfied by transferring promised goods/services to the customer and is measured at the amount of the transaction price allocated to those performance obligations. At the year end, the Trust accrues income relating to performance obligations satisfied in that year. Where the Trust’s entitlement to consideration for those goods or services is unconditional a contract receivable will be recognised. Where entitlement to consideration is conditional on a further factor other than the passage of time, a contract asset will be recognised. Where consideration received or receivable relates to a performance obligation that is to be satisfied in a future period, the income is deferred and recognised as a contract liability.
Revenue from NHS contracts
The main source of income for the Trust is contracts with commissioners for health care services. Funding envelopes are set at an Integrated Care System (ICS) level. The majority of the Trust’s NHS income is earned from NHS commissioners under the NHS Payment Scheme (NHSPS). The NHSPS sets out rules to establish the amount payable to trusts for NHS-funded secondary healthcare.
The Trust also receives income from commissioners under Commissioning for Quality Innovation (CQUIN) and Best Practice Tariff (BPT) schemes. Delivery under these schemes is part of how care is provided to patients. As such CQUIN and BPT payments are not considered distinct performance obligations in their own right; instead they form part of the transaction price for performance obligations under the overall contract with the commissioner and are accounted for as variable consideration under IFRS 15. Payment for CQUIN and BTP on non-elective services is included in the fixed element of API contracts with adjustments for actual achievement being made at the end of the year. BPT earned on elective activity is included in the variable element of API contracts and paid in line with actual activity performed.
Elective recovery funding provides additional funding to integrated care boards to fund the commissioning of elective services within their systems. Trusts do not directly earn elective recovery funding, instead earning income for actual activity performed under API contract arrangements as explained above. The level of activity delivered by the trust contributes to system performance and therefore the availability of funding to the trust’s commissioners.
Note 1.6 Property, plant and equipment
Recognition
Property, plant and equipment is capitalised where:
- it is held for use in delivering services or for administrative purposes;
- it is probable that future economic benefits will flow to, or service potential be provided to, the trust;
- it is expected to be used for more than one financial year;
- the cost of the item can be measured reliably; and • the item has a cost of at least £5,000; or • collectively, a number of items have a cost of at least £5,000 and individually have a cost of more than £250, where the assets are functionally interdependent, they had broadly simultaneous purchase dates, are anticipated to have similar disposal dates and are under single managerial control; or
- items form part of the initial equipping and setting-up cost of a new building or unit, irrespective of their individual or collective cost.
Where a large asset, for example a building, includes a number of components with significantly different asset lives, eg, plant and equipment, then these components are treated as separate assets and depreciated over their own useful economic lives.
Subsequent expenditure
Subsequent expenditure relating to an item of property, plant and equipment is recognised as an increase in the carrying amount of the asset when it is probable that additional future economic benefits or service potential deriving from the cost incurred to replace a component of such item will flow to the enterprise and the cost of the item can be determined reliably. Where a component of an asset is replaced, the cost of the replacement is capitalised if it meets the criteria for recognition above. The carrying amount of the part replaced is de-recognised. Other expenditure that does not generate additional future economic benefits or service potential, such as repairs and maintenance, is charged to the Statement of Comprehensive Income in the period in which it is incurred.
Measurement
Valuation
All property, plant and equipment assets are measured initially at cost, representing the costs directly attributable to acquiring or constructing the asset and bringing it to the location and condition necessary for it to be capable of operating in the manner intended by management.
Assets are measured subsequently at valuation. Assets which are held for their service potential and are in use (ie operational assets used to deliver either front line services or back office functions) are measured at their current value in existing use. Assets that were most recently held for their service potential but are surplus with no plan to bring them back into use are measured at fair value where there are no restrictions on sale at the reporting date and where they do not meet the definitions of investment properties or assets held for sale.
Revaluations of property, plant and equipment are performed with sufficient regularity to ensure that carrying amounts are not materially different from those that would be determined at the end of the reporting period. Current values in existing use are determined as follows:
- Land and non-specialised buildings – market value for existing use
- Specialised buildings – depreciated replacement cost on a modern equivalent asset basis
For specialised assets, current value in existing use is interpreted as the present value of the asset’s remaining service potential, which is assumed to be at least equal to the cost of replacing that service potential. Specialised assets are therefore valued at their depreciated replacement cost (DRC) on a modern equivalent asset (MEA) basis. An MEA basis assumes that the asset will be replaced with a modern asset of equivalent capacity and location requirements of the services being provided. Assets held at depreciated replacement cost have been valued on an alternative site basis where this would meet the location requirements.
Valuation guidance issued by the Royal Institute of Chartered Surveyors states that valuations are performed net of VAT where the VAT is recoverable by the entity.
Properties in the course of construction for service or administration purposes are carried at cost, less any impairment loss. Cost includes professional fees. Assets are revalued and depreciation commences when they are brought into use.
IT equipment, transport equipment, furniture and fittings, and plant and machinery that are held for operational use are valued at depreciated historic cost where these assets have short useful lives or low values or both, as this is not considered to be materially different from current value in existing use.
Depreciation
Items of property, plant and equipment are depreciated over their remaining useful economic lives in a manner consistent with the consumption of economic or service delivery benefits. Freehold land is considered to have an infinite life and is not depreciated.
Property, plant and equipment which has been reclassified as ‘held for sale’ ceases to be depreciated upon the reclassification. Assets in the course of construction are not depreciated until the asset is brought into use or reverts to the trust, respectively.
Revaluation gains and losses
Revaluation gains are recognised in the revaluation reserve, except where, and to the extent that, they reverse a revaluation decrease that has previously been recognised in operating expenses, in which case they are recognised in operating expenditure.
Revaluation losses are charged to the revaluation reserve to the extent that there is an available balance for the asset concerned, and thereafter are charged to operating expenses.
Gains and losses recognised in the revaluation reserve are reported in the Statement of Comprehensive Income as an item of ‘other comprehensive income’.
Impairments
In accordance with the GAM, impairments that arise from a clear consumption of economic benefits or of service potential in the asset are charged to operating expenses. A compensating transfer is made from the revaluation reserve to the income and expenditure reserve of an amount equal to the lower of (i) the impairment charged to operating expenses; and (ii) the balance in the revaluation reserve attributable to that asset before the impairment.
An impairment that arises from a clear consumption of economic benefit or of service potential is reversed when, and to the extent that, the circumstances that gave rise to the loss is reversed. Reversals are recognised in operating expenditure to the extent that the asset is restored to the carrying amount it would have had if the impairment had never been recognised. Any remaining reversal is recognised in the revaluation reserve. Where, at the time of the original impairment, a transfer was made from the revaluation reserve to the income and expenditure reserve, an amount is transferred back to the revaluation reserve when the impairment reversal is recognised. Other impairments are treated as revaluation losses. Reversals of ‘other impairments’ are treated as revaluation gains.
De-recognition
Assets intended for disposal are reclassified as ‘held for sale’ once the criteria in IFRS 5 are met. The sale must be highly probable and the asset available for immediate sale in its present condition.
Following reclassification, the assets are measured at the lower of their existing carrying amount and their ‘fair value less costs to sell’. Depreciation ceases to be charged and the assets are not revalued, except where the ‘fair value less costs to sell’ falls below the carrying amount. Assets are de-recognised when all material sale contract conditions have been met.
Property, plant and equipment which is to be scrapped or demolished does not qualify for recognition as ‘held for sale’ and instead is retained as an operational asset and the asset’s economic life is adjusted. The asset is de-recognised when scrapping or demolition occurs.
Donated, government grant and other grant funded assets
Donated and grant funded property, plant and equipment assets are capitalised at their fair value on receipt. The donation/grant is credited to income at the same time, unless the donor has imposed a condition that the future economic benefits embodied in the grant are to be consumed in a manner specified by the donor, in which case, the donation/grant is deferred within liabilities and is carried forward to future financial years to the extent that the condition has not yet been met.
The donated and grant funded assets are subsequently accounted for in the same manner as other items of property, plant and equipment.
Useful lives of property, plant and equipment
Useful lives reflect the total life of an asset and not the remaining life of an asset. The range of useful lives are shown in the table below:
Min life | Max life | |
---|---|---|
Years | Years | |
Land | Infinite | Infinite |
Buildings, excluding dwellings | 3 | 50 |
Dwellings | – | – |
Plant & machinery | 5 | 10 |
Transport equipment | 5 | 10 |
Information technology | 3 | 5 |
Furniture & fittings | 5 | 5 |
Note 1.7 Intangible assets
Recognition
Intangible assets are non-monetary assets without physical substance controlled by the Trust. They are capable of being sold separately from the rest of the Trust’s business or arise from contractual or other legal rights. Intangible assets are recognised only where it is probable that future economic benefits will flow to, or service potential be provided to, the Trust and where the cost of the asset can be measured reliably.
Internally generated intangible assets
Internally generated goodwill, brands, mastheads, publishing titles, customer lists and similar items are not capitalised as intangible assets.
Expenditure on research is not capitalised. Expenditure on development is capitalised when it meets the requirements set out in IAS 38.
Software
Software which is integral to the operation of hardware, eg an operating system, is capitalised as part of the relevant item of property, plant and equipment. Software which is not integral to the operation of hardware, eg application software, is capitalised as an intangible asset where it meets recognition criteria.
Measurement
Intangible assets are recognised initially at cost, comprising all directly attributable costs needed to create, produce and prepare the asset to the point that it is capable of operating in the manner intended by management.
Subsequently intangible assets are measured at current value in existing use. Where no active market exists, intangible assets are valued at the lower of depreciated replacement cost and the value in use where the asset is income generating. Revaluations gains and losses and impairments are treated in the same manner as for property, plant and equipment. An intangible asset which is surplus with no plan to bring it back into use is valued at fair value where there are no restrictions on sale at the reporting date and where they do not meet the definitions of investment properties or assets held for sale.
Intangible assets held for sale are measured at the lower of their carrying amount or “fair value less costs to sell”.
Amortisation
Intangible assets are amortised over their expected useful lives in a manner consistent with the consumption of economic or service delivery benefits.
Useful lives of intangible assets
Useful lives reflect the total life of an asset and not the remaining life of an asset. The range of useful lives are shown in the table below:
Min life | Max life | |
---|---|---|
Years | Years | |
Intangible assets – internally generated | ||
Information technology | 5 | 5 |
Development expenditure | 5 | 5 |
Websites | 5 | 5 |
Intangible assets – purchased | ||
Software | 5 | 5 |
Licences & trademarks | 5 | 5 |
Patents | 5 | 5 |
Other | 5 | 5 |
Goodwill | 5 | 5 |
Note 1.8 Inventories
Inventories are valued at the lower of cost and net realisable value. This is considered to be a reasonable approximation to current cost due to the high turnover of stocks. The cost of inventories is measured using the weighted average cost method.
Between 2020 to 2021 and 2023 to 2024 the Trust received inventories including personal protective equipment from the Department of Health and Social Care at nil cost. In line with the GAM and applying the principles of the IFRS Conceptual Framework, the Trust has accounted for the receipt of these inventories at a deemed cost, reflecting the best available approximation of an imputed market value for the transaction based on the cost of acquisition by the Department. Distribution of inventories by the Department ceased in March 2024.
Note 1.9 Cash and cash equivalents
Cash is cash in hand and deposits with any financial institution repayable without penalty on notice of not more than 24 hours. Cash equivalents are investments that mature in 3 months or less from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.
In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and that form an integral part of the Trust’s cash management. Cash, bank and overdraft balances are recorded at current values.
Note 1.10 Financial assets and financial liabilities
Note 1.10.1 Recognition
Financial assets and financial liabilities arise where the Trust becomes party to the contractual provision of a financial instrument, and as a result has a legal right to receive or a legal obligation to pay cash or another financial instrument, or in the case of trade receivables, when the goods or services have been delivered.The GAM expands the definition of a contract to include legislation and regulations which give rise to arrangements that in all other respects would be a financial instrument and do not give rise to transactions classified as tax by ONS.
This includes the purchase or sale of non-financial items (such as goods or services), which are entered into in accordance with the Trust’s normal purchase, sale or usage requirements and are recognised when, and to the extent which, performance occurs, ie, when receipt or delivery of the goods or services is made.
Note 1.10.2 Classification and measurement
Financial assets and financial liabilities are initially measured at fair value plus or minus directly attributable transaction costs except where the asset or liability is not measured at fair value through income and expenditure. Fair value is taken as the transaction price, or otherwise determined by reference to quoted market prices or valuation techniques.
Financial assets or financial liabilities in respect of assets acquired or disposed of through leasing arrangements are recognised and measured in accordance with the accounting policy for leases described below.
Financial assets are classified as subsequently measured at amortised cost.
Financial liabilities are classified as subsequently measured at amortised cost.
Financial assets and financial liabilities at amortised cost
Financial assets measured at amortised cost are those held with the objective of collecting contractual cash flows and where the cash flows are solely payments of principal and interest. This includes cash equivalents, contract and other receivables, trade and other payables, rights and obligations under lease arrangements and loans receivable and payable.
The Trust’s financial assets comprise cash and cash equivalents, NHS debtors, accrued income and other debtors
After initial recognition, these financial assets and financial liabilities are measured at amortised cost using the effective interest method, less any impairment (for financial assets). The effective interest rate is the rate that exactly discounts estimated future cash payments or receipts through the life of the financial asset or financial liability to the gross carrying amount of the financial asset or to the amortised cost of a financial liablity.
Interest revenue or expense is calculated by applying the effective interest rate to the gross carrying amount of a financial asset or amortised cost of a financial liability and recognised in the Statement of Comprehensive Income as a financing income or expense.
Impairment of financial assets
For all financial assets measured at amortised cost including lease receivables, contract receivables and contract assets, the Trust recognises an allowance for expected credit losses.
The Trust adopts the simplified approach to impairment for contract and other receivables, contract assets and lease receivables, measuring expected losses as at an amount equal to lifetime expected losses. For other financial assets, the loss allowance is initially measured at an amount equal to 12-month expected credit losses (stage 1) and subsequently at an amount equal to lifetime expected credit losses if the credit risk assessed for the financial asset significantly increases (stage 2).
For financial assets carried at amortised cost, the amount of the impairment loss is measured as the difference between the asset’s carrying amount and the present value of the revised future cash flows discounted at the asset’s original effective interest rate. The loss is recognised in expenditure and the carrying amount of the asset is reduced directly or through a provision for impairment of receivables.
For financial assets that have become credit impaired since initial recognition (stage 3), expected credit losses at the reporting date are measured as the difference between the asset’s gross carrying amount and the present value of the estimated future cash flows discounted at the financial asset’s original effective interest rate.
Expected losses are charged to operating expenditure within the Statement of Comprehensive Income and reduce the net carrying value of the financial asset in the Statement of Financial Position.
HM Treasury has ruled that central government bodies may not recognise stage 1 or stage 2 impairments against other government departments, their executive agencies, the Bank of England, Exchequer Funds, and Exchequer Funds’ assets where repayment is ensured by primary legislation. The Trust therefore does not recognise loss allowances for stage 1 or stage 2 impairments against these bodies. Additionally, the Department of Health and Social Care provides a guarantee of last resort against the debts of its arm’s length bodies and NHS bodies (excluding NHS charities), and the Trust does not recognise loss allowances for stage 1 or stage 2 impairments against these bodies.
Note 1.10.3 De-recognition
Financial assets are de-recognised when the contractual rights to receive cash flows from the assets have expired or the Trust has transferred substantially all the risks and rewards of ownership.
Financial liabilities are de-recognised when the obligation is discharged, cancelled or expires.
Note 1.11 Leases
A lease is a contract or part of a contract that conveys the right to use an asset for a period of time in exchange for consideration. An adaptation of the relevant accounting standard by HM Treasury for the public sector means that for NHS bodies, this includes lease-like arrangements with other public sector entities that do not take the legal form of a contract. It also includes peppercorn leases where consideration paid is nil or nominal (significantly below market value) but in all other respects meet the definition of a lease. The trust does not apply lease accounting to new contracts for the use of intangible assets.
The Trust determines the term of the lease term with reference to the non-cancellable period and any options to extend or terminate the lease which the Trust is reasonably certain to exercise.
Note 1.11.1 The trust as lessee
Initial recognition and measurement
At the commencement date of the lease, being when the asset is made available for use, the Trust recognises a right of use asset and a lease liability.
The right of use asset is recognised at cost comprising the lease liability, any lease payments made before or at commencement, any direct costs incurred by the lessee, less any cash lease incentives received. It also includes any estimate of costs to be incurred restoring the site or underlying asset on completion of the lease term.
The lease liability is initially measured at the present value of future lease payments discounted at the interest rate implicit in the lease. Lease payments includes fixed lease payments, variable lease payments dependent on an index or rate and amounts payable under residual value guarantees. It also includes amounts payable for purchase options and termination penalties where these options are reasonably certain to be exercised.
Where an implicit rate cannot be readily determined, the Trust’s incremental borrowing rate is applied. This rate is determined by HM Treasury annually for each calendar year. A nominal rate of 4.72% applied to new leases commencing in 2024 and 4.81% to new leases commencing in 2025.
The Trust does not apply the above recognition requirements to leases with a term of 12 months or less or to leases where the value of the underlying asset is below £5,000, excluding any irrecoverable VAT. Lease payments associated with these leases are expensed on a straight-line basis over the lease term. Irrecoverable VAT on lease payments is expensed as it falls due.
Subsequent measurement
As required by a HM Treasury interpretation of the accounting standard for the public sector, the Trust employs a revaluation model for subsequent measurement of right of use assets, unless the cost model is considered to be an appropriate proxy for current value in existing use or fair value, in line with the accounting policy for owned assets. Where consideration exchanged is identified as significantly below market value, the cost model is not considered to be an appropriate proxy for the value of the right of use asset.
The Trust subsequently measures the lease liability by increasing the carrying amount for interest arising which is also charged to expenditure as a finance cost and reducing the carrying amount for lease payments made. The liability is also remeasured for changes in assessments impacting the lease term, lease modifications or to reflect actual changes in lease payments. Such remeasurements are also reflected in the cost of the right of use asset. Where there is a change in the lease term or option to purchase the underlying asset, an updated discount rate is applied to the remaining lease payments.
Note 1.11.2 The Trust as lessor
The Trust assesses each of its leases and classifies them as either a finance lease or an operating lease. Leases are classified as finance leases when substantially all the risks and rewards of ownership are transferred to the lessee. All other leases are classified as operating leases.
Where the Trust is an intermediate lessor, classification of the sublease is determined with reference to the right of use asset arising from the headlease.
Finance leases
Amounts due from lessees under finance leases are recorded as receivables at the amount of the Trust’s net investment in the leases. Finance lease income is allocated to accounting periods to reflect a constant periodic rate of return on the Trust’s net investment outstanding in respect of the leases.
Operating Leases
Income from operating leases is recognised on a straight-line basis or another systematic basis over the term of the lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised as an expense on a straight-line basis over the lease term.
Note 1.12 Provisions
The Trust recognises a provision where it has a present legal or constructive obligation of uncertain timing or amount, for which it is probable that there will be a future outflow of cash or other resources, and a reliable estimate can be made of the amount. The amount recognised in the Statement of Financial Position is the best estimate of the resources required to settle the obligation. Where the effect of the time value of money is significant, the estimated risk-adjusted cash flows are discounted using HM Treasury’s discount rates effective from 31 March 2025:
Nominal rate | Prior year rate | ||
---|---|---|---|
Short-term | Up to 5 years | 4.03% | 4.26% |
Medium-term | After 5 years up to 10 years | 4.07% | 4.03% |
Long-term | After 10 years up to 40 years | 4.81% | 4.72% |
Very long-term | Exceeding 40 years | 4.55% | 4.40% |
HM Treasury provides discount rates for general provisions on a nominal rate basis. Expected future cash flows are therefore adjusted for the impact of inflation before discounting using nominal rates. The following inflation rates are set by HM Treasury, effective from 31 March 2025:
Inflation rate | Prior year rate | ||
---|---|---|---|
Year 1 | 2.60% | 3.60% | |
Year 2 | 2.30% | 1.80% | |
Into perpetuity | 2.00% | 2.00% |
Early retirement provisions and injury benefit provisions both use the HM Treasury’s post employment benefits discount rate of 2.40% in real terms (prior year: 2.45%).
Clinical negligence costs
NHS Resolution operates a risk pooling scheme under which the Trust pays an annual contribution to NHS Resolution, which, in return, settles all clinical negligence claims. Although NHS Resolution is administratively responsible for all clinical negligence cases, the legal liability remains with the Trust. The total value of clinical negligence provisions carried by NHS Resolution on behalf of the Trust is disclosed at note 34.2 but is not recognised in the Trust’s accounts.
Non-clinical risk pooling
The Trust participates in the Property Expenses Scheme and the Liabilities to Third Parties Scheme. Both are risk pooling schemes under which the Trust pays an annual contribution to NHS Resolution and in return receives assistance with the costs of claims arising. The annual membership contributions, and any “excesses” payable in respect of particular claims are charged to operating expenses when the liability arises.
Note 1.13 Contingencies
Contingent assets (that is, assets arising from past events whose existence will only be confirmed by one or more future events not wholly within the entity’s control) are not recognised as assets, but are disclosed in note 35 where an inflow of economic benefits is probable.
Contingent liabilities are not recognised, but are disclosed in note 35, unless the probability of a transfer of economic benefits is remote.
Contingent liabilities are defined as:
- possible obligations arising from past events whose existence will be confirmed only by the occurrence of one or more uncertain future events not wholly within the entity’s control; or
- present obligations arising from past events but for which it is not probable that a transfer of economic benefits will arise or for which the amount of the obligation cannot be measured with sufficient reliability.
Note 1.14 Public Dividend Capital
Public Dividend Capital (PDC) is a type of public sector equity finance based on the excess of assets over liabilities at the time of establishment of the predecessor NHS Trust. HM Treasury has determined that PDC is not a financial instrument within the meaning of IAS 32.
The Secretary of State can issue new PDC to, and require repayments of PDC from, the Trust. PDC is recorded at the value received.
A charge, reflecting the cost of capital utilised by the Trust, is payable as Public Dividend Capital dividend. The charge is calculated at the rate set by HM Treasury (currently 3.5%) on the average relevant net assets of the Trust during the financial year. Relevant net assets are calculated as the value of all assets less the value of all liabilities, with certain additions and deductions as defined in the PDC dividend policy issued by the Department of Health and Social Care. This policy is available at https://www.gov.uk/government/publications/guidance-on-financing-available-to-nhs-trusts-and-foundation-trusts.
In accordance with the requirements laid down by the Department of Health and Social Care (as the issuer of PDC), the dividend for the year is calculated on the actual average relevant net assets as set out in the “pre-audit” version of the annual accounts. The dividend calculated is not revised should any adjustment to net assets occur as a result the audit of the annual accounts.
Note 1.15 Value Added Tax
Most of the activities of the Trust are outside the scope of VAT and, in general, output tax does not apply and input tax on purchases is not recoverable. Irrecoverable VAT is charged to the relevant expenditure category or included in the capitalised purchase cost of fixed assets. Where output tax is charged or input VAT is recoverable, the amounts are stated net of VAT.
Note 1.16 Climate change levy
Expenditure on the climate change levy is recognised in the Statement of Comprehensive Income as incurred, based on the prevailing chargeable rates for energy consumption.
Note 1.17 Foreign exchange
The functional and presentational currencies of the Trust are sterling.
A transaction which is denominated in a foreign currency is translated into the functional currency at the spot exchange rate on the date of the transaction.
Where the Trust has assets or liabilities denominated in a foreign currency at the Statement of Financial Position date:
- monetary items are translated at the spot exchange rate on 31 March;
- non-monetary assets and liabilities measured at historical cost are translated using the spot exchange rate at the date of the transaction; and
- non-monetary assets and liabilities measured at fair value are translated using the spot exchange rate at the date the fair value was determined.
Exchange gains or losses on monetary items (arising on settlement of the transaction or on re-translation at the Statement of Financial Position date) are recognised in income or expense in the period in which they arise.
Exchange gains or losses on non-monetary assets and liabilities are recognised in the same manner as other gains and losses on these items.
Note 1.18 Third party assets
Assets belonging to third parties in which the Trust has no beneficial interest (such as money held on behalf of patients) are not recognised in the accounts. However, they are disclosed in a separate note to the accounts in accordance with the requirements of HM Treasury’s FReM.
Note 1.19 Losses and special payments
Losses and special payments are items that Parliament would not have contemplated when it agreed funds for the health service or passed legislation. By their nature they are items that ideally should not arise. They are therefore subject to special control procedures compared with the generality of payments. They are divided into different categories, which govern the way that individual cases are handled. Losses and special payments are charged to the relevant functional headings in expenditure on an accruals basis. The losses and special payments note is compiled directly from the losses and compensations register which reports on an accrual basis with the exception of provisions for future losses.
Note 1.20 Gifts
Gifts are items that are voluntarily donated, with no preconditions and without the expectation of any return. Gifts include all transactions economically equivalent to free and unremunerated transfers, such as the loan of an asset for its expected useful life, and the sale or lease of assets at below market value.
Note 1.21 Transfers of functions from/to other NHS bodies
For functions that have been transferred to the Trust from another NHS body, the transaction is accounted for as a transfer by absorption. The assets and liabilities transferred are recognised in the accounts using the book value as at the date of transfer. The assets and liabilities are not adjusted to fair value prior to recognition. The net gain corresponding to the net assets transferred is recognised within income, but not within operating activities.
For property plant and equipment assets and intangible assets, the cost and accumulated depreciation / amortisation balances from the transferring entity’s accounts are preserved on recognition in the Trust’s accounts. Where the transferring body recognised revaluation reserve balances attributable to the assets, the Trust makes a transfer from its income and expenditure reserve to its revaluation reserve to maintain transparency within public sector accounts.
For functions that the Trust has transferred to another NHS body, the assets and liabilities transferred are de-recognised from the accounts as at the date of transfer. The net loss/gain corresponding to the net assets/ liabilities transferred is recognised within expenses / income, but not within operating activities. Any revaluation reserve balances attributable to assets de-recognised are transferred to the income and expenditure reserve.
Note 1.22 Early adoption of standards, amendments and interpretations
No new accounting standards or revisions to existing standards have been early adopted in 2024 to 2025.
Note 1.23 Standards, amendments and interpretations in issue but not yet effective or adopted
The DHSC GAM does not require the following IFRS Standards to be applied in 2024 to 2025:
IFRS 17 Insurance Contracts – The Standard is effective for accounting periods beginning on or after 1 January 2023. IFRS 17 has been adopted by the FReM from 1 April 2025. Adoption of the Standard for NHS bodies will therefore be in 2025 to 2026. The Standard revises the accounting for insurance contracts for the issuers of insurance. Application of this standard from 2025 to 2026 is not expected to have a material impact on the financial statements.
IFRS 18 Presentation and Disclosure in Financial Statements – The Standard is effective for accounting periods beginning on or after 1 January 2027. The Standard is not yet UK endorsed and not yet adopted by the FReM. Early adoption is not permitted. The expected impact of applying the standard in future periods has not yet been assessed.
IFRS 19 Subsidiaries without Public Accountability: Disclosures – The Standard is effective for accounting periods beginning on or after 1 January 2027. The Standard is not yet UK endorsed and not yet adopted by the FReM. Early adoption is not permitted. The expected impact of applying the standard in future periods has not yet been assessed.
Changes to non-investment asset valuation – Following a thematic review of non-current asset valuations for financial reporting in the public sector, HM Treasury has made a number of changes to valuation frequency, valuation methodology and classification which are effective in the public sector from 1 April 2025 with a 5 year transition period. NHS bodies are adopting these changes to an alternative timeline.
Changes to subsequent measurement of intangible assets and PPE classification / terminology to be implemented for NHS bodies from 1 April 2025:
- Withdrawal of the revaluation model for intangible assets. Carrying values of existing intangible assets measured under a previous revaluation will be taken forward as deemed historic cost.
- Removal of the distinction between specialised and non-specialised assets held for their service potential. Assets will be classified according to whether they are held for their operational capacity.
These changes are not expected to have a material impact on these financial statements.
Changes to valuation cycles and methodology to be implemented for NHS bodies in later periods:
- A mandated quinquennial revaluation frequency (or rolling programme) supplemented by annual indexation in the intervening years.
- Removal of the alternative site assumption for buildings valued at depreciated replacement cost on a modern equivalent asset basis. The approach for land has not yet been finalised by HM Treasury.
The impact of applying these changes in future periods has not yet been assessed. PPE and right of use assets currently subject to revaluation have a total book value of £24.1m as at 31 March 2025.
Note 1.24 Critical accounting estimates and judgements
In the application of the Trust’s accounting policies, management is required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from those estimates and the estimates and underlying assumptions are continually reviewed. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period or in the period of the revision and future periods if the revision affects both current and future periods.
Note 1.24.1 Critical judgements in applying accounting policies
The following are the judgements, apart from those involving estimations (see below) that management has made in the process of applying the Trust’s accounting policies and that have the most significant effect on the amounts recognised in the financial statements:
The Trust procures Vehicle Insurance alongside all English Ambulance Services and the Scottish Ambulance Service via a fully tendered Self Insurance arrangement.
In addition to an Annual Premium paid to meet large value claims, the Trust makes payments each year into a ‘Claims Fund’ held by insurers to cover the cost of claims above an agreed excess level up to a maximum level for each claim. This fund remains under the control of the insurers and remaining funds are returned to the Trust once all claims for a year are settled.
As in previous years, any potential return of funds are not accrued as an asset or income in the Trust’s accounts as in the Trust’s view it does not meet the definition of an asset, being controlled not by the Trust but by the insurer as a fund for the insurer to settle claims from. An amount is recognised by the Trust only when released by the insurer and paid to the Trust as a confirmed settlement of a period which is closed and where the surplus balance is not required to settle claims.
The Trust has applied this approach consistently from one accounting period to the next. The values involved have not required a separate accounting policy in the financial statements.
Note 1.24.2 Key sources of estimation uncertainty
The following are assumptions about the future and other major sources of estimation uncertainty that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next financial year:
There is uncertainty around the future direction of commercial property prices. The Trust adopted a formal revaluation during 2024 to 2025 and then intends to revalue every 5 years in line with IAS 16. Between valuations the Trust adjusts the values of its Land and Buildings assets by applying indexation provided by a company of professional valuers.
Operating Segments
The Trust operated as one segment to provide an emergency healthcare service to the West Midlands area.
The Trust considers that disclosure of separate segments should occur where that segment accounts for more than 10% of total operating revenue.
The chief operating decision maker for the Trust is the Trust Board which receives a financial report containing summarised financial results at each Trust Board meeting.
Note 3 Operating income from patient care activities
All income from patient care activities relates to contract income recognised in line with accounting policy 1.2.1
Note 3.1 Income from patient care activities (by nature) | 2024 to 2025 | 2023 to 2024 |
---|---|---|
£000 | £000 | |
Ambulance services | ||
A & E income | 363,410 | 327,634 |
Patient transport services income | 53,267 | 50,502 |
Other income | 5,022 | 10,041 |
Community services | ||
Income from commissioners under API contracts* | – | – |
Income from other sources (e.g. local authorities) | – | – |
All services | ||
Private patient income | – | – |
National pay award central funding*** | – | – |
Additional pension contribution central funding** | 21,137 | 13,099 |
Other clinical income | – | – |
Total income from activities | 442,836 | 401,276 |
**Increases to the employer contribution rate for NHS pensions since 1 April 2019 have been funded by NHS England. NHS providers continue to pay at the former rate of 14.3% with the additional amount being paid over by NHS England on providers’ behalf. The full cost of employer contributions (23.7%, 2023 to 2024: 20.6%) and related NHS England funding (9.4%, 2023 to 2024: 6.3%) have been recognised in these accounts.
Note 3.2 Income from patient care activities (by source)
2024 to 2025 | 2023 to 2024 | |
---|---|---|
Income from patient care activities received from: | £000 | £000 |
NHS England | 21,137 | 14,557 |
Integrated care boards | 415,581 | 374,252 |
Department of Health and Social Care | – | – |
Other NHS providers | 4,942 | 11,257 |
NHS other | – | – |
Local authorities | 4 | 6 |
Non-NHS: private patients | – | – |
Non-NHS: overseas patients (chargeable to patient) | – | – |
Injury cost recovery scheme | 525 | 596 |
Non NHS: other | 647 | 608 |
Total income from activities | 442,836 | 401,276 |
Of which: | ||
Related to continuing operations | 442,836 | 401,276 |
Related to discontinued operations | – | – |
Note 3.3 Overseas visitors (relating to patients charged directly by the provider)
The Trust does not receive income from overseas visitors.
Note 4 Other operating income | 2024 to 2025 | 2023 to 2024 | ||||
---|---|---|---|---|---|---|
Contract income | Non-contract income | Total | Contract income | Non-contract income | Total | |
£000 | £000 | £000 | £000 | £000 | £000 | |
Research and development | 246 | – | 246 | 349 | – | 349 |
Education and training | 7,953 | – | 7,953 | 6,995 | – | 6,995 |
Non-patient care services to other bodies | 1,068 | 1,068 | 373 | 373 | ||
Income in respect of employee benefits accounted on a gross basis | 648 | 648 | 2,431 | 2,431 | ||
Receipt of capital grants and donations and peppercorn leases | 1,029 | 1,029 | 314 | 314 | ||
Charitable and other contributions to expenditure | – | – | 34 | 34 | ||
Support from the Department of Health and Social Care for mergers | – | – | – | – | ||
Revenue from finance leases (variable lease receipts) | – | – | – | – | ||
Revenue from operating leases | – | – | – | – | ||
Amortisation of PFI deferred income / credits | – | – | – | – | ||
Other income | 2,819 | – | 2,819 | 2,536 | – | 2,536 |
Total other operating income | 12,734 | 1,029 | 13,763 | 12,684 | 348 | 13,032 |
Of which: | ||||||
Related to continuing operations | 13,763 | 13,032 | ||||
Related to discontinued operations | – | – |
Note 5.1 Additional information on contract revenue (IFRS 15) recognised in the period
The Trust has no revenue recognised from performance obligations satisfied (or partially satisfied) in previous periods
Note 5.2 Transaction price allocated to remaining performance obligations
The Trust has no revenue recognised from existing contracts.
Note 5.3 Income from activities arising from commissioner requested services
The trust is required to analyse the level of income from activities that has arisen from commissioner requested and non-commissioner requested services. Commissioner requested services are defined in the provider licence and are services that commissioners believe would need to be protected in the event of provider failure. This information is provided in the table below:
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
Income from services designated as commissioner requested services | 442,836 | 401,276 |
Income from services not designated as commissioner requested services | 13,763 | 13,032 |
Total | 456,599 | 414,308 |
Note 5.4 Profits and losses on disposal of property, plant and equipment
No land and building assets used in the provision of commissioner requested services have been disposed of during the year. In the prior year the Trust sold the West Bromwich Ambulance Station site. The Sandwell site now provides these services. The net book value of the asset was £523k and the proceeds of sale were £480k.
Note 5.5 Fees and charges
The Trusts does not have income from charges to service users.
Note 6 Operating leases – West Midlands Ambulance Service University NHS Foundation Trust as lessor
This note discloses income generated in operating lease agreements where West Midlands Ambulance Service University NHS Foundation Trust is the lessor.
The Trust does not have any operating lease agreements for which it is a lessor in either the current or prior year.
Note 7.1 Operating expenses
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
Purchase of healthcare from NHS and DHSC bodies | – | – |
Purchase of healthcare from non-NHS and non-DHSC bodies | – | – |
Purchase of social care | – | – |
Staff and executive directors costs | 349,420 | 305,423 |
Remuneration of non-executive directors | 175 | 160 |
Supplies and services – clinical (excluding drugs costs) | 7,910 | 7,450 |
Supplies and services – general | 3,891 | 3,666 |
Drug costs (drugs inventory consumed and purchase of non-inventory drugs) | 863 | 985 |
Inventories written down | – | – |
Consultancy costs | 126 | 202 |
Establishment | 7,124 | 7,011 |
Premises | 12,064 | 13,812 |
Transport (including patient travel) | 25,925 | 27,513 |
Depreciation on property, plant and equipment | 24,916 | 24,093 |
Amortisation on intangible assets | 427 | 460 |
Net impairments | 3,583 | (21) |
Movement in credit loss allowance: contract receivables / contract assets | 23 | 35 |
Movement in credit loss allowance: all other receivables and investments | – | – |
Increase/(decrease) in other provisions | – | – |
Change in provisions discount rate(s) | 2 | (41) |
Fees payable to the external auditor | ||
audit services- statutory audit | 124 | 120 |
other auditor remuneration (external auditor only) | – | – |
Internal audit costs | 158 | 658 |
Clinical negligence | 4,195 | 3,503 |
Legal fees | 597 | 199 |
Insurance | 2,769 | 1,894 |
Research and development | 172 | 331 |
Education and training | 6,961 | 6,461 |
Expenditure on short term leases | 6,415 | 4,393 |
Expenditure on low value leases | – | – |
Variable lease payments not included in the liability | – | – |
Early retirements | – | – |
Redundancy | – | 140 |
Charges to operating expenditure for on-SoFP IFRIC 12 schemes (e.g. PFI / LIFT) | – | – |
Charges to operating expenditure for off-SoFP PFI / LIFT schemes | – | – |
Car parking & security | – | – |
Hospitality | 68 | 63 |
Losses, ex gratia & special payments | 6 | 19 |
Grossing up consortium arrangements | – | – |
Other services, eg external payroll | – | – |
Other | (1,940) | 3,973 |
Total | 455,974 | 412,502 |
Of which: | ||
Related to continuing operations | 455,974 | 412,502 |
Related to discontinued operations | – | – |
Audit services statutory audit – net of VAT £104k (2023 to 2024 £100k)
Other expenditure includes the release of a legal provision. This relates to the settlement of the legal claim, lodged against the Trust and NHS England, following a legal mediation agreement in May 2024. HM Treasury approval was received in March 2025.
Note 7.2 Other auditor remuneration
The Trust did not pay any other auditor remuneration to the external auditor in the current or prior year.
Note 7.3 Limitation on auditor’s liability
The limitation on auditor’s liability for external audit work is £1,000k (2023 to 2024: £1,000k).
Note 8 Impairment of assets
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
Net impairments charged to operating surplus / deficit resulting from: | ||
Loss or damage from normal operations | – | – |
Over specification of assets | – | – |
Abandonment of assets in course of construction | – | – |
Unforeseen obsolescence | – | – |
Loss as a result of catastrophe | – | – |
Changes in market price | 3,583 | (21) |
Other | – | – |
Total net impairments charged to operating surplus / deficit | 3,583 | (21) |
Impairments charged to the revaluation reserve | 1,509 | – |
Total net impairments | 5,092 | (21) |
An impairment for Millenium Point has been recognised arising from the quinquenial revaluation exercise. Millenium Point is the head quarters building used by the trust. The amount impaired is £2.4m. The asset has been valued at value in existing use.
Note 9 Employee benefits
2024 to 2025 | 2023 to 2024 | |
---|---|---|
Total | Total | |
£000 | £000 | |
Salaries and wages | 272,288 | 241,124 |
Social security costs | 25,947 | 24,529 |
Apprenticeship levy | 1,350 | 1,274 |
Employer’s contributions to NHS pensions | 53,587 | 43,089 |
Pension cost – other | – | – |
Other post employment benefits | – | – |
Other employment benefits | – | – |
Termination benefits | – | – |
Temporary staff (including agency) | 0 | 0 |
Total gross staff costs | 353,172 | 310,016 |
Recoveries in respect of seconded staff | – | – |
Total staff costs | 353,172 | 310,016 |
Of which | ||
Costs capitalised as part of assets | – | – |
Note 9.1 Retirements due to ill-health
During 2024 to 2025 there were 2 early retirements from the trust agreed on the grounds of ill-health (3 in the year ended 31 March 2024). The estimated additional pension liabilities of these ill-health retirements is £178k (£122k in 2023 to 2024).
These estimated costs are calculated on an average basis and will be borne by the NHS Pension Scheme.
Note 10 Pension costs
Past and present employees are covered by the provisions of the NHS Pension Schemes. Details of the benefits payable and rules of the schemes can be found on the NHS Pensions website at www.nhsbsa.nhs.uk/pensions. Both the 1995 to 2008 and 2015 schemes are accounted for, and the scheme liability valued, as a single combined scheme. Both are unfunded defined benefit schemes that cover NHS employers, GP practices and other bodies, allowed under the direction of the Secretary of State for Health and Social Care in England and Wales. They are not designed to be run in a way that would enable NHS bodies to identify their share of the underlying scheme assets and liabilities. Therefore, each scheme is accounted for as if it were a defined contribution scheme: the cost to the NHS body of participating in each scheme is taken as equal to the contributions payable to that scheme for the accounting period.
In order that the defined benefit obligations recognised in the financial statements do not differ materially from those that would be determined at the reporting date by a formal actuarial valuation, the FReM requires that “the period between formal valuations shall be four years, with approximate assessments in intervening years”. An outline of these follows:
a) Accounting valuation
A valuation of scheme liability is carried out annually by the scheme actuary (currently the Government Actuary’s Department) as at the end of the reporting period. This utilises an actuarial assessment for the previous accounting period in conjunction with updated membership and financial data for the current reporting period, and is accepted as providing suitably robust figures for financial reporting purposes. The valuation of the scheme liability as at 31 March 2025, is based on valuation data as at 31 March 2023, updated to 31 March 2025 with summary global member and accounting data. In undertaking this actuarial assessment, the methodology prescribed in IAS 19, relevant FReM interpretations, and the discount rate prescribed by HM Treasury have also been used.
The latest assessment of the liabilities of the scheme is contained in the Statement by the Actuary,which forms part of the annual NHS Pension Scheme Annual Report and Accounts. These accounts can be viewed on the NHS Pensions website and are published annually. Copies can also be obtained from The Stationery Office.
b) Full actuarial (funding) valuation
The purpose of this valuation is to assess the level of liability in respect of the benefits due under the schemes (considering recent demographic experience), and to recommend the contribution rate payable by employers.
The latest actuarial valuation undertaken for the NHS Pension Scheme was completed as at 31 March 2020. The results of this valuation set the employer contribution rate payable from 1 April 2024 to 23.7% of pensionable pay. The core cost cap cost of the scheme was calculated to be outside of the 3% cost cap corridor as at 31 March 2020. However, when the wider economic situation was taken into account through the economic cost cap cost of the scheme, the cost cap corridor was not similarly breached. As a result, there was no impact on the member benefit structure or contribution rates.
The 2024 actuarial valuation is currently being prepared and will be published before new contribution rates are implemented from April 2027.
Note 11 Finance income
Finance income represents interest received on assets and investments in the period.
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
Interest on bank accounts | 1,727 | 2,266 |
Interest income on finance leases | – | – |
Interest on other investments / financial assets | – | – |
Other finance income | – | – |
Total finance income | 1,727 | 2,266 |
Note 12.1 Finance expenditure
Finance expenditure represents interest and other charges involved in the borrowing of money or asset financing.
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
Interest expense: | ||
Interest on loans from the Department of Health and Social Care | – | – |
Interest on other loans | – | – |
Interest on overdrafts | – | – |
Interest on lease obligations | 501 | 408 |
Interest on late payment of commercial debt | – | – |
Finance costs on PFI, LIFT and other service concession arrangements: | ||
Main finance costs | – | – |
Contingent finance costs | – | – |
Remeasurement of the liability resulting from change in index or rate | – | – |
Total interest expense | 501 | 408 |
Unwinding of discount on provisions | 44 | 44 |
Other finance costs | – | – |
Total finance costs | 545 | 452 |
Note 12.2 The late payment of commercial debts (interest) Act 1998
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
Total liability accruing in year under this legislation as a result of late payments | – | – |
Amounts included within interest payable arising from claims made under this legislation | – | – |
Compensation paid to cover debt recovery costs under this legislation | – | – |
Note 13 Other gains / (losses)
2024 to 2025 | 2023 to 2024 | |
£000 | £000 | |
Gains on disposal of assets | 245 | 154 |
Losses on disposal of assets | (18) | (201) |
Total gains / (losses) on disposal of assets | 227 | (47) |
Gains / (losses) on foreign exchange | – | – |
Fair value gains / (losses) on investment properties | – | – |
Fair value gains / (losses) on financial assets / investments | – | – |
Fair value gains / (losses) on financial liabilities | – | – |
Recycling gains / (losses) on disposal of financial assets mandated as fair value through OCI | – | – |
Gains/(losses) on remeasurement of finance lease receivables (lessor) | – | – |
Gains/(losses) on termination of finance leases (lessor) | – | – |
Other gains / (losses) | – | – |
Total other gains / (losses) | 227 | (47) |
Note 14 Discontinued operations
The Trust did not discontinue any operations in either the current or prior year.
Note 15.1 Intangible assets – 2024 to 2025
Software licences | Development expenditure | Total | |
---|---|---|---|
£000 | £000 | £000 | |
Valuation / gross cost at 1 April 2024 – brought forward | 1,259 | 1,782 | 3,041 |
Additions | 285 | – | 285 |
Disposals / derecognition | (227) | – | (227) |
Valuation / gross cost at 31 March 2025 | 1,317 | 1,782 | 3,099 |
Amortisation at 1 April 2024 – brought forward | 740 | 1,144 | 1,884 |
Provided during the year | 208 | 219 | 427 |
Disposals / derecognition | (227) | – | (227) |
Amortisation at 31 March 2025 | 721 | 1,363 | 2,084 |
Net book value at 31 March 2025 | 596 | 419 | 1,015 |
Net book value at 1 April 2024 | 519 | 638 | 1,157 |
Note 15.2 Intangible assets – 2023 to 2024
Software licences | Development expenditure | Total | |
---|---|---|---|
£000 | £000 | £000 | |
Valuation / gross cost at 1 April 2023 – as previously stated | 1,085 | 1,867 | 2,952 |
Additions | 347 | 100 | 447 |
Disposals / derecognition | (173) | (185) | (358) |
Valuation / gross cost at 31 March 2024 | 1,259 | 1,782 | 3,041 |
Amortisation at 1 April 2023 – restated | 750 | 1,032 | 1,782 |
Provided during the year | 163 | 297 | 460 |
Disposals / derecognition | (173) | (185) | (358) |
Amortisation at 31 March 2024 | 740 | 1,144 | 1,884 |
Net book value at 31 March 2024 | 519 | 638 | 1,157 |
Net book value at 1 April 2023 | 335 | 835 | 1,170 |
Note 16.1 Property, plant and equipment – 2024 to 2025
Land | Buildings excluding dwellings | Assets under construction | Plant & machinery | Transport equipment | Information technology | Furniture & fittings | Total | |
---|---|---|---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
Valuation/gross cost at 1 April 2024 – brought forward | 3,824 | 34,747 | 6,540 | 15,636 | 64,499 | 19,361 | 1,161 | 145,768 |
Additions | – | 778 | 2,133 | 1,985 | 6,038 | 1,895 | – | 12,829 |
Impairments | (203) | (5,026) | – | – | – | – | – | (5,229) |
Reversals of impairments | 104 | 33 | – | – | – | – | – | 137 |
Revaluations | 677 | 2,326 | – | – | – | – | – | 3,003 |
Reclassifications | – | 36 | (5,964) | 1,492 | 4,377 | 59 | – | – |
Transfers to / from assets held for sale | – | (2,858) | – | – | – | – | – | (2,858) |
Disposals / derecognition | – | (620) | – | (883) | (5,312) | (1,891) | – | (8,706) |
Valuation/gross cost at 31 March 2025 | 4,402 | 29,416 | 2,709 | 18,230 | 69,602 | 19,424 | 1,161 | 144,944 |
Accumulated depreciation at 1 April 2024 – brought forward | – | 9,377 | – | – | 9,147 | 34,732 | 14,883 | 1,031 | 69,170 |
Provided during the year | – | 1,302 | – | – | 2,525 | 11,548 | 1,765 | 57 | 17,197 |
Transfers to / from assets held for sale | – | (368) | – | – | – | – | – | – | (368) |
Disposals / derecognition | – | (620) | – | – | (882) | (4,899) | (1,887) | – | (8,288) |
Accumulated depreciation at 31 March 2025 | – | 9,691 | – | – | 10,790 | 41,381 | 14,761 | 1,088 | 77,711 |
Net book value at 31 March 2025 | 4,402 | 19,725 | – | 2,709 | 7,440 | 28,221 | 4,663 | 73 | 67,233 |
Net book value at 1 April 2024 | 3,824 | 25,370 | – | 6,540 | 6,489 | 29,767 | 4,478 | 130 | 76,598 |
Note 16.3 Property, plant and equipment financing – 31 March 2025
Land | Buildings excluding dwellings | Dwellings | Assets under construction | Plant & machinery | Transport equipment | Information technology | Furniture & fittings | Total | |
---|---|---|---|---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
Owned – purchased | 4,402 | 19,725 | – | 1,680 | 7,251 | 28,221 | 4,663 | 73 | 66,015 |
On-SoFP PFI contracts and other service concession arrangements | – | – | – | – | – | – | – | – | – |
Off-SoFP PFI residual interests | – | – | – | – | – | – | – | – | – |
Owned – donated/granted | – | – | – | 1,029 | 189 | – | – | – | 1,218 |
Total net book value at 31 March 2025 | 4,402 | 19,725 | – | 2,709 | 7,440 | 28,221 | 4,663 | 73 | 67,233 |
Note 16.4 Property, plant and equipment financing – 31 March 2024
Land | Buildings excluding dwellings | Dwellings | Assets under construction | Plant & machinery | Transport equipment | Information technology | Furniture & fittings | Total | |
---|---|---|---|---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
Owned – purchased | 3,824 | 25,370 | – | 6,540 | 6,237 | 29,767 | 4,478 | 130 | 76,346 |
On-SoFP PFI contracts and other service concession arrangements | – | – | – | – | – | – | – | – | – |
Off-SoFP PFI residual interests | – | – | – | – | – | – | – | – | – |
Owned – donated/granted | – | – | – | – | 252 | – | – | – | 252 |
Total net book value at 31 March 2024 | 3,824 | 25,370 | – | 6,540 | 6,489 | 29,767 | 4,478 | 130 | 76,598 |
Note 17 Donations of property, plant and equipment
The Trust had no material donations of property, plant and equipment received during the year.
Note 18 Revaluations of property, plant and equipment
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
At start of period | 9,756 | 9,908 |
Impairments | (1,509) | – |
Revaluations | 3,003 | 261 |
Asset disposals | (6) | (413) |
Fair Value gains/(losses) on Available-for-sale financial investments | – | – |
Revaluation reserve at 31 March | 11,244 | 9,756 |
Freehold and leasehold properties owned by West Midlands Ambulance Service were valued as at 31 December 2024 by an external valuer, Newmark Gerald Eve LLP, a regulated firm of Chartered Surveyors. The valuations were prepared in accordance with the requirements of the RICS Valuation – Global Standards 2022 and the national standards and guidance set out in the UK supplement 2024, the International Valuation Standards and IFRS as adapted and interpreted by the Financial Reporting Manual (FReM). The valuation of the operational properties was in accordance with Existing Use Value with specialised properties valued using a Depreciated Replacement Cost (DRC) method because of the specialised nature of the asset means there are no market transactions of this type, except as part of the business or entity.
Note 19 Leases – West Midlands Ambulance Service University NHS Foundation Trust as a lessee
This note details information about leases for which the Trust is a lessee.
Leases are for vehicles, property occupied and IT equipment.
Note 19.1 Right of use assets – 2024 to 2025
Property (land and buildings) | Transport equipment | Information technology | Total | Of which: leased from DHSC group bodies | |
---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | |
Valuation / gross cost at 1 April 2024 – brought forward | 43,675 | 11,763 | – | 55,438 | – |
Transfers by absorption | – | (309) | – | (309) | – |
Additions | – | 10,831 | 947 | 11,778 | – |
Remeasurements of the lease liability | 46 | – | – | 46 | – |
Disposals / derecognition | (455) | (2,910) | – | (3,365) | – |
Valuation/gross cost at 31 March 2025 | 43,266 | 19,375 | 947 | 63,588 | – |
Accumulated depreciation at 1 April 2024 – brought forward | 4,659 | 6,193 | – | 10,852 | – |
Transfers by absorption | – | (112) | – | (112) | – |
Provided during the year | 4,401 | 3,297 | 21 | 7,719 | – |
Disposals / derecognition | (455) | (2,910) | – | (3,365) | – |
Accumulated depreciation at 31 March 2025 | 8,605 | 6,468 | 21 | 15,094 | – |
Net book value at 31 March 2025 | 34,661 | 12,907 | 926 | 48,494 | – |
Net book value at 1 April 2024 | 39,016 | 5,570 | – | 44,586 | – |
Net book value of right of use assets leased from other NHS providers
Net book value of right of use assets leased from other DHSC group bodies
Note 19.2 Right of use assets – 2023 to 2024
Property (land and buildings) | Transport equipment | Information technology | Total | Of which: leased from DHSC group bodies | |
---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | |
Valuation / gross cost at 1 April 2023 – brought forward | 37,561 | 12,732 | – | 50,293 | – |
Transfers by absorption | – | – | – | – | – |
Additions | – | 488 | – | 488 | – |
Remeasurements of the lease liability | 3,047 | – | – | 3,047 | – |
Movements in provisions for restoration / removal costs | 3,067 | – | – | 3,067 | – |
Disposals / derecognition | – | (1,457) | – | (1,457) | – |
Valuation/gross cost at 31 March 2024 | 43,675 | 11,763 | – | 55,438 | – |
Accumulated depreciation at 1 April 2023 – brought forward | 1,875 | 4,074 | – | 5,949 | – |
Transfers by absorption | – | – | – | – | – |
Provided during the year | 2,784 | 3,535 | – | 6,319 | – |
Disposals / derecognition | – | (1,416) | – | (1,416) | – |
Accumulated depreciation at 31 March 2024 | 4,659 | 6,193 | – | 10,852 | – |
Net book value at 31 March 2024 | 39,016 | 5,570 | – | 44,586 | – |
Net book value at 1 April 2023 | 35,686 | 8,658 | – | 44,344 | – |
Net book value of right of use assets leased from other NHS providers
Net book value of right of use assets leased from other DHSC group bodies
Note 45 provides further details on the transfer by absorption
Note 19.3 Revaluations of right of use assets
The Trust has not used the revaluation model in IAS 16 in measuring right of use assets.
Note 19.4 Reconciliation of the carrying value of lease liabilities
Lease liabilities are included within borrowing in the statement of financial position. A breakdown of borrowing is disclosed in note 32.1.
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
Carrying value at 1 April | 39,816 | 41,863 |
Transfers by absorption | (176) | – |
Lease additions | 11,778 | 488 |
Lease liability remeasurements | 46 | 3,047 |
Interest charge arising in year | 501 | 408 |
Early terminations | – | (13) |
Lease payments (cash outflows) | (7,409) | (5,977) |
Other changes | – | – |
Carrying value at 31 March | 44,556 | 39,816 |
Lease payments for short term leases, leases of low value underlying assets and variable lease payments not dependent on an index or rate are recognised in operating expenditure.
These payments are disclosed in Note 7.1. Cash outflows in respect of leases recognised on-SoFP are disclosed in the reconciliation above.
Income generated from subleasing right of use assets is £0k and is included within revenue from operating leases in note 4.
Note 19.5 Maturity analysis of future lease payments
Total | Of which leased from DHSC group bodies: | Total | Of which leased from DHSC group bodies: | |
---|---|---|---|---|
31 March 2025 | 31 March 2025 | 31 March 2024 | 31 March 2024 | |
£000 | £000 | £000 | £000 | |
Undiscounted future lease payments payable in: | ||||
– not later than one year; | 7,213 | – | 4,386 | – |
– later than one year and not later than five years; | 14,776 | – | 10,689 | – |
– later than five years. | 27,504 | – | 29,115 | – |
Total gross future lease payments | 49,493 | – | 44,190 | – |
Finance charges allocated to future periods | (4,937) | – | (4,374) | – |
Net lease liabilities at 31 March 2025 | 44,556 | – | 39,816 | – |
Of which: | ||||
Leased from other NHS providers | – | – | ||
Leased from other DHSC group bodies | – | – |
Note 19.6 Leases – other information
The portfolio of short terms leases to which the Trust is committed at the end of the reporting period is not dissimilar to the portfolio of short term leases for which expense has beenThe Trust had no investments in associates or joint ventures in the current or previous accounting periods.
Note 22 Other investments / financial assets (non-current) incurred in year. Therefore no further disclosure is provided.
Note 20 Investment Property
The Trust had no investment property in 2024 to 2025 or 2023 to 2024.
Note 20.1 Investment property income and expenses
The Trust had no investment property income and expenses in 2024 to 2025 or 2023 to 2024.
Note 21 Investments in associates and joint ventures
The Trust had no investments in associates or joint ventures in the current or previous accounting periods.
Note 22 Other investments / financial assets (non-current)
The Trust had no other non current investments or financial assets in the current or previous accounting periods.
Note 22.1 Other investments / financial assets (current)
The Trust had no other current investments or financial assets in the current or previous accounting periods.
Note 23 Disclosure of interests in other entities
The Trust held no interests in other entities at 31 March 2025 or 31 March 2024.
Note 24 Inventories
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Drugs | 241 | 221 |
Consumables | 2,733 | 3,324 |
Total inventories | 2,974 | 3,545 |
of which: | ||
Held at fair value less costs to sell- | – | – |
Inventories recognised in expenses for the year were £17,574k (2023 to 2024: £16,363k). Write-down of inventories recognised as expenses for the year were £0k (2023 to 2024: £0k).
Note 25.1 Receivables
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Current | ||
Contract receivables | 6,604 | 5,570 |
Allowance for impaired contract receivables / assets | (750) | (727) |
Prepayments (non-PFI) | 10,917 | 8,194 |
PDC dividend receivable | – | 69 |
VAT receivable | 644 | 699 |
Total current receivables | 17,415 | 13,805 |
Non-current | ||
Contract receivables | 676 | 704 |
Total non-current receivables | 676 | 704 |
Of which receivable from NHS and DHSC group bodies: | ||
Current | 3,909 | 3,710 |
Non-current | – | – |
Note 25.2 Allowances for credit losses
2024 to 2025 | 2023 to 2024 | |||
---|---|---|---|---|
Contract receivables and contract assets | All other receivables | Contract receivables and contract assets | All other receivables | |
£000 | £000 | £000 | £000 | |
Allowances as at 1 April – brought forward | – | 692 | – | |
Prior period adjustments | – | – | ||
Allowances as at 1 April – restated | – | – | 692 | – |
New allowances arising | 23 | – | 35 | – |
Allowances as at 31 Mar 2025 | 23 | – | 727 | – |
The provision for impairment of receivables is based on Non NHS debts outstanding over 3 months old. The provision also includes a provision of 24.45% (23.07% 31 March 2024) for doubtful recovery of the income from the NHS Injury Recovery Scheme, which amounts to £448k.
Note 25.3 Exposure to credit risk
Because the majority of the West Midlands Ambulance Service University NHS Foundation Trust’s income comes from contracts with other NHS bodies, the Trust has low exposure to credit risk. The maximum exposures as at 31 March 2025 are in receivables from customers.
Note 26 Finance leases (West Midlands Ambulance Service University NHS Foundation Trust as a lessor)
This note discloses future lease payments receivable from lease arrangements classified as finance leases where the West Midlands Ambulance Service NHS Foundation Trust is the lessor.
The Trust had no finance lease arrangements as a lessor in either the current or previous accounting periods.
Note 27 Other assets
The Trust had no Other Assets in either the current or previous accounting periods.
Note 28.1 Non-current assets held for sale and assets in disposal groups
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
NBV of non-current assets for sale and assets in disposal groups at 1 April | 619 | |
Assets classified as available for sale in the year | 2,490 | – |
Assets sold in year | – | (619) |
NBV of non-current assets for sale and assets in disposal groups at 31 March | 2,490 | – |
The assets held for sale relate to Navigation Point and Warwick Ambulance Station. The functions used in the premises have been transferred to other sites. The assets are currently being marketed for sale.
Note 28.2 Liabilities in disposal groups
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Categorised as: | ||
Provisions | – | – |
Trade and other payables | – | – |
Other | – | – |
Total | – | – |
Note 29.1 Cash and cash equivalents movements
Cash and cash equivalents comprise cash at bank, in hand and cash equivalents. Cash equivalents are readily convertible investments of known value which are subject to an insignificant risk of change in value.
2024 to 2025 | 2023 to 2024 | |
---|---|---|
£000 | £000 | |
At 1 April | 36,463 | 33,223 |
Net change in year | (920) | 3,240 |
At 31 March | 35,543 | 36,463 |
Broken down into: | ||
Cash at commercial banks and in hand | 8 | 28 |
Cash with the Government Banking Service | 35,535 | 36,435 |
Total cash and cash equivalents as in SoFP | 35,543 | 36,463 |
Bank overdrafts (GBS and commercial banks) | – | – |
Drawdown in committed facility | – | – |
Total cash and cash equivalents as in SoCF | 35,543 | 36,463 |
Note 29.2 Third party assets held by the trust
West Midlands Ambulance Service University NHS Foundation Trust held cash and cash equivalents which relate to monies held by the Trust on behalf of patients or other parties and in which the trust has no beneficial interest. This has been excluded from the cash and cash equivalents figure reported in the accounts.
There were no third party assets or patients money held by the West Midlands Ambulance Service University NHS Foundation Trust in either the current or previous accounting periods.
Note 30.1 Trade and other payables
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Current | ||
Trade payables | 3,169 | 3,180 |
Capital payables | 2,146 | 1,003 |
Accruals | 14,119 | 20,010 |
Social security costs | 6,704 | 6,334 |
PDC dividend payable | 235 | – |
Pension contributions payable | 4,490 | 4,158 |
Total current trade and other payables | 30,863 | 34,685 |
Non-current | ||
Trade payables | – | – |
Capital payables | – | – |
Accruals | – | – |
Total non-current trade and other payables | – | – |
Of which payables from NHS and DHSC group bodies: | ||
Current | 771 | 1,306 |
Non-current | – | – |
Note 30.2 Early retirements in NHS payables above
There were no early retirement payments.
Note 31 Other liabilities
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Current | ||
Deferred income: contract liabilities | 531 | 319 |
Total other current liabilities | 531 | 319 |
Non-current | ||
Deferred income: contract liabilities | – | – |
Total other non-current liabilities | – | – |
Note 32.1 Borrowings
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Current | ||
Lease liabilities | 7,213 | 4,386 |
Total current borrowings | 7,213 | 4,386 |
Non-current | ||
Lease liabilities | 37,343 | 35,430 |
Total non-current borrowings | 37,343 | 35,430 |
Note 32.2 Reconciliation of liabilities arising from financing activities
Lease Liabilities | Total | |
---|---|---|
£000 | £000 | |
Carrying value at 1 April 2024 | 39,816 | 39,816 |
Cash movements: | ||
Financing cash flows – payments and receipts of principal | (6,908) | (6,908) |
Financing cash flows – payments of interest | (501) | (501) |
Non-cash movements: | ||
Transfers by absorption | (176) | (176) |
Additions | 11,778 | 11,778 |
Lease liability remeasurements | 46 | 46 |
Application of effective interest rate | 501 | 501 |
Early terminations | – | – |
Carrying value at 31 March 2025 | 44,556 | 44,556 |
Lease Liabilities | Total | |
---|---|---|
£000 | £000 | |
Carrying value at 1 April 2023 | 41,863 | 41,863 |
Cash movements: | ||
Financing cash flows – payments and receipts of principal | (5,605) | (5,605) |
Financing cash flows – payments of interest | (372) | (372) |
Non-cash movements: | ||
Additions | 488 | 488 |
Lease liability remeasurements | 3,047 | 3,047 |
Application of effective interest rate | 408 | 408 |
Early terminations | (13) | (13) |
Carrying value at 31 March 2024 | 39,816 | 39,816 |
Note 33 Other financial liabilities
The Trust had no other financial liabilities in either the current or previous accounting periods.
Note 34.1 Provisions for liabilities and charges analysis
Pensions: early departure costs | Pensions: injury benefits | Legal claims | Other | Total | |
---|---|---|---|---|---|
£000 | £000 | £000 | £000 | £000 | |
At 1 April 2024 | 184 | 1,637 | 3,784 | 4,980 | 10,585 |
Transfers by absorption | – | – | – | – | – |
Change in the discount rate | – | 2 | – | – | 2 |
Arising during the year | 29 | 251 | 201 | 745 | 1,226 |
Utilised during the year | (40) | (282) | (1,576) | (400) | (2,298) |
Reclassified to liabilities held in disposal groups | – | – | – | – | – |
Reversed unused | – | – | (2,175) | (451) | (2,626) |
Unwinding of discount | 4 | 40 | – | – | 44 |
At 31 March 2025 | 177 | 1,648 | 234 | 4,874 | 6,933 |
Expected timing of cash flows: | |||||
– not later than one year; | 37 | 283 | 135 | 2,950 | 3,405 |
– later than one year and not later than five years; | 140 | 1,365 | 99 | 1,924 | 3,528 |
– later than five years. | – | – | – | – | – |
Total | 177 | 1,648 | 234 | 4,874 | 6,933 |
Pensions relating to staff represent the value of Pre:1995 early retirement cases capitalised as a prior year adjustment in 2002 to 2003.
Legal claims represent outstanding employer’s liability and a legal claim lodged against the Trust and NHS England following a legal mediation agreement in May 2024. HM Treasury approval was received in March 2025 to settle the legal claim.
Injury benefits represent outstanding injury benefit cases.
Other provisions include leased vehicle dilapidations, leased building dilapidations and HMRC review of VAT allowances.
Where the effect of the time value of money is significant, the estimated risk-adjusted cash flows are discounted using the Treasury’s discount rate as stated in note 1.12.
Note 34.2 Clinical negligence liabilities
At 31 March 2025, £45,679k was included in provisions of NHS Resolution in respect of clinical negligence liabilities of West Midlands Ambulance Service University NHS Foundation Trust (31 March 2024: £40,725k).
Note 35 Contingent assets and liabilities
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Value of contingent liabilities | ||
Other | (71) | (107) |
Gross value of contingent liabilities | (71) | (107) |
Amounts recoverable against liabilities | – | – |
Net value of contingent liabilities | (71) | (107) |
Net value of contingent assets | – | – |
Contingent Liabilities represent outstanding employer’s liability legal claims, as notified by NHS Resoution which, at this stage, are not deemed certain enough to include within the provision for liabilities and charges (note 34.1). The value of the uncertainty of the liability is determined by NHS Resolution according to the nature and details of each individual case.
Note 36 Contractual capital commitments
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
Property, plant and equipment | 20,539 | 4,485 |
Intangible assets | – | – |
Total | 20,539 | 4,485 |
Capital commitments include commitments for fleet. Lease agreements are agreed as necessary and therefore there is no confimed lease commitment at present.
Note 37 Other financial commitments
The Trust had no other financial commitments.
Note 38 Defined benefit pension schemes
The Trust had no defined benefit pension schemes in either the current or previous accounting periods.
Note 39 On-SoFP PFI, LIFT or other service concession arrangements
The Trust had no on-SoFP PFI, LIFT or other service concession arrangements in either the current or previous accounting periods.
Note 40 Off-SoFP PFI, LIFT and other service concession arrangements
The Trust had no off-SoFP PFI, LIFT or other service concession arrangements in either the current or previous accounting periods.
Note 41 Financial instruments
Note 41.1 Financial risk management
Financial reporting standard IFRS 7 requires disclosure of the role that financial instruments have had during the period in creating or changing the risks a body faces in undertaking its activities. Because of the continuing service provider relationship that the West Midlands Ambulance Service University NHS Foundation Trust has with Integrated Care Boards and the way those Integrated Care Boards are financed, the Trust is not exposed to the degree of financial risk faced by business entities. Also, financial instruments play a much more limited role in creating or changing risk than would be typical of listed companies, to which the financial reporting standards mainly apply. The Trust has limited powers to borrow or invest surplus funds and financial assets and liabilities are generated by day-to-day operational activities rather than being held to change the risks facing the Trust in undertaking its activities.
The West Midlands Ambulance Service University NHS Foundation Trust’s treasury management operations are carried out by the Finance department, within parameters defined formally within the Trust’s Standing Financial Instructions and Policies agreed by the Board of Directors. Trust treasury activity is subject to review by the Trust’s internal auditors.
Currency risk
The West Midlands Ambulance Service University NHS Foundation Trust is principally a domestic organisation with the great majority of transactions, assets and liabilities being in the UK and sterling based. The Trust has no overseas operations. The Trust therefore has low exposure to currency rate fluctuations.
Interest rate risk
The West Midlands Ambulance Service University NHS Foundation Trust has no borrowings from government and therefore has low exposure to interest rate fluctuations.
Credit risk
Because the majority of the West Midlands Ambulance Service University NHS Foundation Trust’s income comes from contracts with other public sector bodies, the Trust has low exposure to credit risk. The maximum exposures as at 31 March 2025 are in receivables from customers, as disclosed in ‘Trade and Other Receivables’ (Note 25).
Liquidity risk
The West Midlands Ambulance Service University NHS Foundation Trust’s operating costs are incurred under contracts with Integrated Care Boards, which are financed from resources voted annually by Parliament . The Trust funds its capital expenditure from funds generated from operations, which is acknowledged by the Commissioners. The Trust is not, therefore, exposed to significant liquidity risks.
Note 41.2 Carrying values of financial assets
Carrying values of financial assets as at 31 March 2025 | Held at amortised cost | Held at fair value through I&E | Held at fair value through OCI | Total book value |
---|---|---|---|---|
£000 | £000 | £000 | £000 | |
Trade and other receivables excluding non financial assets | 6,530 | – | – | 6,530 |
Other investments / financial assets | – | – | – | – |
Cash and cash equivalents | 35,543 | – | – | 35,543 |
Total at 31 March 2025 | 42,073 | – | – | 42,073 |
Carrying values of financial assets as at 31 March 2024 | Held at amortised cost | Held at fair value through I&E | Held at fair value through OCI | Total book value |
---|---|---|---|---|
£000 | £000 | £000 | £000 | |
Trade and other receivables excluding non financial assets | 5,547 | – | – | 5,547 |
Other investments / financial assets | – | – | – | – |
Cash and cash equivalents | 36,463 | – | – | 36,463 |
Total at 31 March 2024 | 42,010 | – | – | 42,010 |
Note 41.3 Carrying values of financial liabilities | ||||
Carrying values of financial liabilities as at 31 March 2025 | Held at amortised cost | Held at fair value through I&E | Total book value | |
£000 | £000 | £000 | ||
Loans from the Department of Health and Social Care | – | – | – | |
Obligations under leases | 44,556 | – | 44,556 | |
Obligations under PFI, LIFT and other service concession contracts | – | – | – | |
Other borrowings | – | – | – | |
Trade and other payables excluding non financial liabilities | 15,978 | – | 15,978 | |
Other financial liabilities | – | – | – | |
Provisions under contract | – | – | – | |
Total at 31 March 2025 | 60,534 | – | 60,534 |
Note 41.3 Carrying values of financial liabilities
Carrying values of financial liabilities as at 31 March 2025 | Held at amortised cost | Held at fair value through I&E | Total book value |
---|---|---|---|
£000 | £000 | £000 | |
Loans from the Department of Health and Social Care | – | – | – |
Obligations under leases | 44,556 | – | 44,556 |
Obligations under PFI, LIFT and other service concession contracts | – | – | – |
Other borrowings | – | – | – |
Trade and other payables excluding non financial liabilities | 15,978 | – | 15,978 |
Other financial liabilities | – | – | – |
Provisions under contract | – | – | – |
Total at 31 March 2025 | – | 60,534 |
Carrying values of financial liabilities as at 31 March 2024 | Held at amortised cost | Held at fair value through I&E | Total book value |
---|---|---|---|
£000 | £000 | £000 | |
Loans from the Department of Health and Social Care | – | – | – |
Obligations under leases | 39,816 | – | 39,816 |
Obligations under PFI, LIFT and other service concession contracts | – | – | – |
Other borrowings | – | – | – |
Trade and other payables excluding non financial liabilities | 24,842 | – | 24,842 |
Other financial liabilities | – | – | – |
Provisions under contract | – | – | – |
Total at 31 64,658 March 2024 | – | 64,658 |
Note 41.4 Maturity of financial liabilities
The following maturity profile of financial liabilities is based on the contractual undiscounted cash flows. This differs to the amounts recognised in the statement of financial position which are discounted to present value.
31 March 2025 | 31 March 2024 | |
---|---|---|
£000 | £000 | |
In one year or less | 23,191 | 29,228 |
In more than one year but not more than five years | 14,776 | 10,689 |
In more than five years | 27,504 | 29,115 |
Total | 65,471 | 69,032 |
Note 41.5 Fair values of financial assets and liabilities
Book value (carrying value) is a reasonable approximation of fair value.
Note 42 Losses and special payments
2024 to 2025 Total number of cases | Total value of cases | 2023 to 2024 Total number of cases | Total value of cases | |
---|---|---|---|---|
Number | £000 | Number | £000 | |
Losses | ||||
Stores losses and damage to property | 9 | 6 | 11 | 19 |
Total losses | 9 | 6 | 11 | 19 |
Special payments | ||||
Ex-gratia payments | 1 | 1,500 | – | – |
Special severance payments | 2 | 53 | 2 | 21 |
Total special payments | 3 | 1,553 | 2 | 21 |
Total losses and special payments | 12 | 1,559 | 13 | 40 |
Compensation payments received |
The ex-gratia payment for £1.5m relates to the settlement of a legal claim, lodged against the Trust and NHS England, following a legal mediation agreement in May 2024. HM Treasury approval was received in March 2025.
Note 43 Gifts
There were no gifts over £300k either as a total or individually for 2024 to 2025 or 2023/ to 2024.
Note 44 Related parties
West Midlands Ambulance Service University NHS Foundation Trust is a body corporate authorised under section 35 on the National Health Service Act 2006
During the period none of the Board members or members of the key management staff or parties related to them has undertaken any material transactions with West Midlands Ambulance Service University NHS Foundation Trust.
All the Board members of West Midlands Ambulance Service University NHS Foundation Trust are trustees of the West Midlands Ambulance Service Charitable Fund.
The Department of Health and Social Care is regarded as a related party. During the period West Midlands Ambulance Service University NHS Foundation Trust has had a significant number of material transactions with the department and with other entities for which the Department is regarded as the parent Department including NHS England. The key entities are listed below:
Entities are listed below where values exceed £10m
- NHS Birmingham and Solihull ICB
- NHS Black Country ICB
- NHS Cheshire and Merseyside ICB
- NHS Coventry and Warwickshire ICB
- NHS Herefordshire and Worcestershire ICB
- NHS Shropshire, Telford and Wrekin ICB
- NHS Staffordshire and Stoke-on-Trent ICB
In addition, the Trust has had a number of material transactions with other government departments and other central and local government bodies. Most of these transactions have been with HM Revenue and Customs with regard to income tax, national insurance and VAT, the Department of Works and Pensions with regard to the injury allowance scheme and the NHS Pensions Agency with regard to both employee and employer pension contributions.
Note 45 Transfers by absorption
The National Ambulance Resilience Unit (NARU) service contract was awarded to London Ambulance Service NHS Trust as from 1 April 2024. The transfer by absorption relates to the divesting of IFRS 16 lease contracts to London Ambulance Service on 1 April 2024. The loss on transfer totalled £21k.
Right of Use Asset Net book value | £197k |
Lease liability value | (£176k) |
Loss on transfer | £21k |
Note 46 Prior period adjustments
There were no prior period adjustments in the year by the Trust for 2024 to 2025 (nil, 2023 to 2024)
Note 47 Events after the reporting date
There were no events of note after the current reporting period ends.